Stay updated on Durvalumab with Chemoradiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab with Chemoradiation in Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab with Chemoradiation in Lung Cancer Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov site revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check10 days agoChange DetectedA banner announces NIH website transition updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.SummaryDifference0.4%

- Check17 days agoChange DetectedThe footer now displays software revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check24 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check45 days agoChange DetectedThe study record history now includes the latest page revision tag v3.7.0 and removes the previous v3.6.6 tag, reflecting an update to the page's version history. This change represents an update to how the page versions are tracked rather than content changes.SummaryDifference0.1%

- Check66 days agoChange DetectedA new revision entry (v3.6.6) was added to the study record history, and the previous revision (v3.6.5) was removed from the history list, updating the record's version history.SummaryDifference0.1%

Stay in the know with updates to Durvalumab with Chemoradiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab with Chemoradiation in Lung Cancer Clinical Trial page.